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On the basis of the finding that the
homeostasis of dermal DCs can be
modulated by epidermal keratinocytes, it
is tempting to speculate that interac-
tion between the epidermis and DC may
be one of the mechanisms that integrates
the dermal immune system. Further
studies are necessary to understand how
this mechanism works under physiol-
ogical conditions and whether it fails in
certain skin disorders, such as psoriasis,
where the amount of TGFb1 is correlated
with the severity of the disease (Kallimanis
et al., 2009). Normalizing keratinocyte/
DC interplay through TGFb1 may be a
novel therapeutic approach for psoriasis
and related inflammatory skin diseases.
The study by Mohammed et al. (2012)
provides new insight into cutaneous bio-
logy. To further understand its signifi-
cance, it will be interesting to address
whether transient induction of TGFb1
has other effects, in addition to promo-
ting immune responses. As DNFB, which
Mohammed et al. used to induce contact
hypersensitivity, is a hapten with strong
immunogenicity, the enhanced response
in the presence of transient TGFb1 induc-
tion during sensitization could have been
influenced by the inflammatory cyto-
kine milieu (such as IL-1b and IL-18)
produced by DNFB-stimulated keratino-
cytes (Figure 1c). On the other hand, tran-
sient induction of TGFb1 in the absence
of inflammatory stimuli may induce tole-
rance to antigens. In addition, it is impor-
tant to ask why TGFb1 affects only certain
subsets of DC, and what the roles of each
DC subset are in the context of skin
inflammation. The effect of TGFb1 on
immune cells other than DCs, viz T cells,
B cells, and macrophages, is another
interesting issue that needs to be explored.
It should be noted that TGFb1 exerts
its function in a context-dependent man-
ner. Given that overexpression of TGFb1
by keratinocytes in vivo is likely to
occur under inflammatory conditions,
it would be useful to know how kerati-
nocyte-derived TGFb1 regulates skin
DCs under physiological conditions,
where the amount of TGFb1 is likely
to be much lower. Such knowledge will
provide a better understanding of the
pathogenesis of inflammatory skin dis-
orders, such as psoriasis. The mouse
model developed by Mohammed et al.
(2012) should be a very powerful tool
for clarifying the mysterious roles of
TGFb1 in other fields, such as embryo-
genesis, morphogenesis, tissue repair,
tumorigenesis, and inflammation.
REFERENCES
Bettelli E, Carrier Y, Gao W et al. (2006) Recipro-
cal developmental pathways for the genera-
tion of pathogenic effector TH17 and
regulatory T cells. Nature 441:235–8
Blobe GC, Schiemann WP, Lodish HF (2000) Role
of transforming growth factor beta in human
disease. N Engl J Med 342:1350–8
Egawa G, Honda T, Tanizaki H et al. (2011) In vivo
imaging of T-cell motility in the elicitation phase
of contact hypersensitivity using two-photon
microscopy. J Invest Dermatol 131:977–9
Egawa G, Kabashima K (2011) Skin as a peripheral
lymphoid organ: revisiting the concept of
skin-associated lymphoid tissues. J Invest
Dermatol 131:2178–85
Fitch EL, Rizzo HL, Kurtz SE et al. (2009) Inflamma-
tory skin disease in K5.hTGF-beta1 transgenic
mice is not dependent on the IL-23/Th17 inflam-
matory pathway. J Invest Dermatol 129:2443–50
Han G, Williams CA, Salter K et al. (2010) A role
for TGFbeta signaling in the pathogenesis of
psoriasis. J Invest Dermatol 130:371–7
Honda T, Egawa G, Grabbe S et al. (2012) Update of
immune events in the murine contact hyper-
sensitivity model: toward the understanding
of allergic contact dermatitis. J Invest Dermatol;
e-pub ahead of print 30 August 2012
Kallimanis PG, Xenos K, Markantonis SL et al.
(2009) Serum levels of transforming growth
factor-beta1 in patients with mild psoriasis
vulgaris and effect of treatment with biologi-
cal drugs. Clin Exp Dermatol 34:582–6
Li AG, Wang D, Feng XH et al. (2004) Latent
TGFbeta1 overexpression in keratinocytes
results in a severe psoriasis-like skin disorder.
Embo J 23:1770–81
Li MO, Wan YY, Sanjabi S et al. (2006) Transform-
ing growth factor-beta regulation of immune
responses. Annu Rev Immunol 24:99–146
Liu X, Alexander V, Vijayachandra K et al. (2001)
Conditional epidermal expression of TGFbeta
1 blocks neonatal lethality but causes a
reversible hyperplasia and alopecia. Proc Natl
Acad Sci USA 98:9139–44
Michaelis K, Wallbrecht K, Kerstan A et al. (2010)
Modulating T cell functions does not alleviate
chronic inflammatory skin lesions in K5.TGF
beta 1 transgenic mice. Exp Dermatol 19:406–15
Mohammed J, Gunderson AJ, Khong HH et al. (2012)
TGFb1 overexpression by keratinocytes alters skin
dendritic cell homeostasis and enhances contact
hypersensitivity. J Invest Dermatol 133:135–43
Rubtsov YP, Rudensky AY (2007) TGFbeta
signalling in control of T-cell-mediated self-
reactivity. Nat Rev Immunol 7:443–53
Veldhoen M, Stockinger B (2006) TGFbeta1, a
‘‘Jack of all trades’’: the link with pro-
inflammatory IL-17-producing T cells. Trends
Immunol 27:358–61
Wahl SM (1994) Transforming growth factor beta:
the good, the bad, and the ugly. J Exp Med
180:1587–90
Cutaneous Pigmentation in Health and
Disease: Novel and Well-Established
Players
Mina Yaar1
Cutaneous pigment formation and aberration in disease are addressed. Dynoodt
et al. (this issue) present data on a specific micro RNA that downregulates proteins
involved in melanogenesis and melanosome movement. Kim et al. (this issue)
present data showing that Wnt signaling is involved in the pathogenesis of
melasma. Both articles enhance our understanding of cutaneous pigmentation
and point to targets in the development of novel therapeutic modalities.
Journal of Investigative Dermatology (2013) 133, 11–13. doi:10.1038/jid.2012.442
Melanin is a complex biopolymer that is
synthesized in melanocytes, stored in cyto-
plasmic organelles called melanosomes,
and provides protection against UV-
induced damage by absorbing and scat-
tering UV radiation (reviewed in Park
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and Yaar, 2012). Besides its role in
protecting against UV-induced damage,
melanin is the major determinant of skin
and hair color. A better understanding of
the complex process of melanogenesis,
its dysregulation during disease pro-
cesses, and how it is influenced by UV
radiation will facilitate the development
of new therapeutic modalities to address
pigmentary disorders and possibly
protective sunless tanning.
Melanogenesis, the synthesis and dis-
tribution of melanin in the epidermis,
involves several steps: transcription of
proteins required for melanogenesis;
melanosome biogenesis; sorting of mel-
anogenic proteins into melanosomes;
transport of melanosomes to the tips of
melanocyte dendrites, and transfer of
melanosomes to keratinocytes. Disrup-
tions in any of these events may result in
hypopigmentation or hyperpigmenta-
tion. Melanin synthesis is largely influ-
enced by UV radiation, as well as by
positive and negative signals from
neighboring keratinocytes and to a les-
ser degree from dermal fibroblasts.
As is true of cellular constituents,
melanin synthesis and transfer to kerati-
nocytes is controlled by an array of
genes whose transcription leads to
mRNA synthesis. mRNAs carry coding
information to ribosomes where protein
synthesis takes place. mRNAs are partly
regulated by micro RNAs (miRNA),
which are small post-transcriptional
molecules that bind to complementary
sequences on mRNAs and affect mRNA
stability and translational capacity
(Elbashir et al., 2001).
Tyrosinase, the enzyme that catalyzes
the first two steps in melanin biosynth-
esis, is the rate-limiting enzyme in mel-
anin biosynthesis, and it resides within
melanosomes. Tyrosinase-related pro-
tein 1 (TRP-1), an enzyme that is struc-
turally related to tyrosinase, is
complexed with tyrosinase within the
melanosomes and likely affects tyrosi-
nase activation and/or stability. Tyrosi-
nase and TRP-1 transcription is partly
upregulated by the nuclear transcription
factor microphthalmia-associated tran-
scription factor (MITF), which also
enhances melanocyte survival (reviewed
in Park and Yaar, 2012). MITF
transcription is upregulated by the
transcription factor SOX9 (Figure 1).
Another important regulator of MITF
transcription is a-melanocyte-stimulat-
ing hormone (a-MSH), a naturally
occurring endogenous peptide hormone
that binds to its melanocortin receptor-1
(MCR-1) on melanocytes to induce a
signal transduction pathway leading to
increased cellular cAMP and resulting in
MITF transcription (Figure 1; reviewed
in Park and Yaar, 2012). Interestingly, it
is possible to increase intracellular
levels of cAMP independent of a-MSH
and MCR-1 using forskolin, an organic
compound produced by the Indian plant
Coleus forskohlii (Figure 1; D’Orazio
et al., 2006). Thus, forskolin is an
MITF transcription modulator. MITF
transcription is also upregulated by the
Wnt family of proteins. These
extracellular signaling molecules bind
to Frizzled receptors and induce intra-
cellular signal transduction pathways
that result in MITF transcription
(Figure 1; reviewed in Park and Yaar,
2012). Conversely, Wnt proteins are
inhibited by a secreted lipid-binding
protein called Wnt inhibitory factor-1
(WIF-1) (Hsieh et al., 1999), which is
primarily of keratinocyte and fibroblast
origin (Gudjonsson et al., 2010). By
binding Wnt proteins, WIF-1 interferes
with their activity and consequently
inhibits MITF transcription.
An important part of cutaneous pig-
mentation is the transfer of melano-
somes to keratinocytes. This requires
proper melanocyte dendrite formation
and proper transport of melanosomes to
Clinical Implications
 A novel miRNA (miR-145) that downregulates proteins involved in mela-
nogenesis and melanosome movement along melanocyte dendrites is
reported.
Wnt/WIF-1 signaling is causally related to melasma.
 These observations may lead to novel methods of treating pigmentary
disorders, including melasma.
Figure 1. Microphthalmia-associated transcription factor (MITF) transcription regulation. MITF
transcription is upregulated by the transcription factor SOX9. a-Melanocyte-stimulating hormone (a-MSH)
binds to melanocortin receptor-1 (MCR-1) on melanocytes to induce a signal transduction pathway leading
to increased cellular cAMP resulting in MITF transcription. Forskolin increases cellular cAMP inducing
MITF transcription. Wnt binds Frizzled and induces intracellular signal transduction pathways that result in
MITF transcription. WIF-1 inhibits MITF transcription by binding Wnt.
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the tip of the dendrites. Actin is a major
structural component of melanocyte
dendrites, and actin filament disruption
leads to dendrite loss. Fascin homolog 1
(Fscn1) is a protein that assists in orga-
nizing filamentous actin into bundles,
and thus is crucial for dendrite forma-
tion (Duh et al., 1994). Within each
dendrite, melanosomes are attached to
microtubules, cylindrical polymers of
tubulin that are important components
of the cytoskeleton. Melanosomes move
bidirectionally along these microtubules
within dendrites, and their movement is
facilitated by two motor proteins that are
attached to the melanosome and to the
microtubules (reviewed in Park and
Yaar, 2012). Centrifugal, anterograde
melanosome movement is primarily
mediated by the motor protein kinesin,
whereas their centripetal, retrograde
movement is controlled by the motor
protein cytoplasmic dynein. The net
result of melanosome movement is
ultimately forward and they finally
reach the tips of dendrites, where they
are captured in the actin-rich periphery.
There, a small protein, myosin-5a,
mediates melanosome binding to actin
through two linker proteins Rab27a and
melanophilin (reviewed in Park and
Yaar, 2012).
In this issue of the Journal of Investi-
gative Dermatology, two articles
enhance our understanding of cuta-
neous pigmentation and how it is
affected in melasma. Dynoodt et al.
(2012) address the question of which
miRNAs are involved in melanogenesis.
By using an immortalized cell line of
mouse melanocytes, melan-A, the
authors observed that solar-simulated
irradiation of the cells together with
forskolin leads to the upregulation/
downregulation of several miRNAs, the
most prominent of which is miR-145,
whose levels are downregulated 15-fold
by this treatment. Indeed, overexpres-
sion of miR-145 in melan-A cells results
in downregulation of myosin-5a,
Rab27a, tyrosinase, and Fscn1 proteins.
As expected, miR-145 overexpression
interfered with melanosomal migration
along the dendrites, and in these cells
melanosomes aggregated around the
nuclei.
In the second article, Kim et al. (2012)
examined WIF-1 and Wnt expression in
the skin of patients with melasma and
compared it with normal controls. Mel-
asma is a hyperpigmentary disorder
affecting many darker-skinned indivi-
duals including Hispanics, Asians, and
Middle Easterners. It is related to sun
exposure and to hormones such as those
used in oral contraceptives and those
present during pregnancy. The authors
observed increased Wnt expression in
the skin of melasma patients compared
with that of normal controls, as well as
decreased WIF-1 expression in keratino-
cytes in the skin of patients with mel-
asma. Knocking down WIF-1 expression
in cultured keratinocytes and/or fibro-
blasts increased tyrosinase expression in
keratinocyte/melanocyte cocultures and
enhanced melanosome transfer to kera-
tinocytes. This was reversed by treating
the melanocyte monocultures or kerati-
nocyte/melanocyte cocultures with
rhWIF-1, suggesting that melasma is
causally related to disruption of the
Wnt signaling pathway.
The importance of the first study is the
identification of a previously unknown
molecule miR-145, which appears to be
central to the pigmentary process. The
second study identifies, at least in part, a
mechanism involved in melasma devel-
opment. These studies provide good
examples of how molecular biological
techniques may be used to dissect the
complex cellular pathways that control
pigmentation and to identify specific
molecules involved in the pigmentation
process. It is possible that these mole-
cules will be future targets manipulating
pigmentation. For example, the miRNA
effect could be inhibited by small inter-
fering RNA (siRNA). It has been shown
in other systems, including in vivo in
cardiac disease, that specially designed
siRNAs bind miRNA precursors, deplet-
ing the miRNAs and neutralizing their
effects (Li et al., 2009). Such an
approach could be used to target key
miRNAs involved in pigmentation
through effects on the expression and
activity of several downstream genes.
The second study reasserts the
importance of signals from neighboring
keratinocytes and fibroblasts in the
control of melanin synthesis and
suggests that targeting keratinocytes,
cells that are readily accessible to
external manipulation, could be used
to modulate pigmentary processes in the
skin.
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